Farallon Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Hold |
2,000
| – | – | ﹤0.01% | 100 |
|
|
2025
Q1 | $361K | Hold |
2,000
| – | – | ﹤0.01% | 95 |
|
|
2024
Q4 | $313K | Hold |
2,000
| – | – | ﹤0.01% | 101 |
|
|
2024
Q3 | $364K | Hold |
2,000
| – | – | ﹤0.01% | 108 |
|
|
2024
Q2 | $367K | Hold |
2,000
| – | – | ﹤0.01% | 108 |
|
|
2024
Q1 | $356K | Hold |
2,000
| – | – | ﹤0.01% | 124 |
|
|
2023
Q4 | $248K | Hold |
2,000
| – | – | ﹤0.01% | 117 |
|
|
2023
Q3 | $232K | Buy |
+2,000
| New | +$232K | ﹤0.01% | 123 |
|
|
2021
Q3 | – | Sell |
-75,000
| Closed | -$5.1M | – | 303 |
|
|
2021
Q2 | $5.1M | Sell |
75,000
-550,000
| -88% | -$37.4M | 0.02% | 172 |
|
|
2021
Q1 | $48.2M | Buy |
625,000
+100,000
| +19% | +$7.7M | 0.24% | 71 |
|
|
2020
Q4 | $31.5M | Buy |
525,000
+50,000
| +11% | +$3M | 0.19% | 77 |
|
|
2020
Q3 | $20.4M | Buy |
475,000
+25,000
| +6% | +$1.08M | 0.14% | 82 |
|
|
2020
Q2 | $18.6M | Buy |
450,000
+200,000
| +80% | +$8.28M | 0.15% | 89 |
|
|
2020
Q1 | $10.8M | Buy |
+250,000
| New | +$10.8M | 0.09% | 76 |
|